Theriva Biologics Inc (TOVX)
0.4061
0.00 (0.00%)
USD |
NYAM |
May 01, 16:00
0.40
-0.01
(-1.49%)
After-Hours: 07:44
Theriva Biologics Cash from Investing (Quarterly): -0.056M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.056M |
September 30, 2023 | -0.129M |
June 30, 2023 | -0.009M |
March 31, 2023 | -0.008M |
December 31, 2022 | -0.091M |
September 30, 2022 | -0.011M |
June 30, 2022 | -0.014M |
March 31, 2022 | -4.28M |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | -0.014M |
December 31, 2020 | -0.005M |
September 30, 2020 | -0.004M |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | -0.007M |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | -0.003M |
Date | Value |
---|---|
September 30, 2017 | -0.198M |
June 30, 2017 | 0.00 |
March 31, 2017 | -0.011M |
December 31, 2016 | -0.37M |
September 30, 2016 | -0.154M |
June 30, 2016 | -0.001M |
March 31, 2016 | -0.044M |
December 31, 2015 | -0.044M |
September 30, 2015 | -0.396M |
June 30, 2015 | -0.043M |
March 31, 2015 | -0.018M |
December 31, 2014 | -0.005M |
September 30, 2014 | -0.022M |
June 30, 2014 | -0.017M |
March 31, 2014 | -0.004M |
December 31, 2013 | -0.011M |
September 30, 2013 | -0.012M |
June 30, 2013 | -0.01M |
March 31, 2013 | -0.003M |
December 31, 2012 | -0.003M |
September 30, 2012 | -0.007M |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 2.79M |
September 30, 2011 | -2.866M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-4.28M
Minimum
Mar 2022
--
Maximum
Jun 2019
-0.2432M
Average
-0.005M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.002M |
Palatin Technologies Inc | 9.462M |
iBio Inc | 0.00 |
Oragenics Inc | -1.00M |
Nanoviricides Inc | -0.0055M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -6.541M |
Cash from Financing (Quarterly) | -1.457M |
Free Cash Flow | -19.20M |
Free Cash Flow Per Share (Quarterly) | -0.3864 |
Free Cash Flow Yield | -293.6% |